CORDIS Archive

View the original page arrowbar Legal Noticebar Print the page
This page has been archived. It will no longer be updated.

23486 PHASE

A Distributed Pharmaceutical Applications Server

Keywords: High-Performance Computing and Networking
Technical - Metacomputing, Parallel computing, Simulation, Internet
Uses - Molecular modeling
Industrial Applications - Drug design, biotechnology research

The PHASE project aims at providing a central access point to powerful computing platforms running applications used in the pharmaceutical drug discovery process (e.g. MaxHom, Genequiz, Dragon and Msap). By linking WAN connected HPCN systems running these applications, a service is provided to industrial users who need high performance computing power for their specific tasks in drug design projects, but find the cost to be prohibitive, or have not decided yet to invest in the acquisition and management of the software and platforms.

Building on previous projects, and on a national metacomputing initiative, PHASE combines important paralel bio-informatics applications for collaborative use in a distributed server environment.

Based on the results and experiences gained in these projects, PHASE has the potential to demonstrate the feasibility and cost-effectiveness of HPCN in industrial key-applications in the field of pharmaceutical drug design, and in biotechnology research.

Moreover the project intends to demonstrate that this type of service, accessible also through Internet, may be extended to other application codes, and other industrial sectors.

Contact Point

Mrs Anke Weber
tel +49.5251.60.6331
University Paderborn
fax +49.5251.60.6297
Paderborn Centre of Parallel Computing
email: weber@uni-paderborn.de
Fürstenallee 11
http://www.uni-paderborn.de/pc2/projects/phase
D-33102 Paderborn

Participants

Country

Role

PC²

D

C

Merck

D

P

Novo

DK

P

EBI

UK

P

MRC-NIMR

UK

P

OML

UK

A

Start Date

Duration

February 1997

24 months

This page is located at /esprit/src/23486.htm
It was last updated on 18 November 1998, and is maintained by

Massimo.Luciolli@cec.be